Clinical Trials Directory

Trials / Completed

CompletedNCT05143320

Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection

Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: an Italian Sample.

Status
Completed
Phase
Study type
Observational
Enrollment
29 (actual)
Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

Recent studies suggest cognitive, emotional and behavioural impairments occur in patients after SARS-CoV-2 infection. Problems with memory, attention, information processing and executive functions are particularly prevalent in these patients, probably due to hypothesised sensitivity of the hippocampus to the virus. Cognitive impairment is also present in patients with no neurological, neuropsychological and neuropsychiatric history. Therefore, the aim of the present study is to describe neuropsychological and neuropsychiatric features in patients recovered from moderate to severe forms of Covid-19 some weeks after hospital dismission.

Conditions

Timeline

Start date
2021-01-08
Primary completion
2021-05-21
Completion
2021-10-29
First posted
2021-12-03
Last updated
2021-12-03

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05143320. Inclusion in this directory is not an endorsement.